Navigation Links
Interview with Medical College of Wisconsin Research Foundation's new director of marketing and licensing

A fish tale that is about more than the one that got away


Dr. Carl Clark illustrates how large the fish were
MILWAUKEE The Medical College of Wisconsin is expanding its efforts to commercialize the products of its research. It reached an important milestone July 1, when Dr. Carl Clar......

Full article >>> s second attempt at obtaining fish serum involved traveling to a commercial fishery on Lake Michigan and borrowing some unwanted carp. A daylong field trip to the fishery involved eight university employees and yielded just 100 milliliters of serum.

"It was an expensive proposition," Clark recalled.

Clark knew he could obtain fish serum more efficiently than the group had, so he ......

Full article >>> ke in the eye with a sharp stick. Especially for two days' work."

The most valuable by-product of Clark's fish business was his increased appetite for new business challenges. "The take-home message is that if you're in the right place at the right time with the right idea, you can make a lot of money," Clark said.

Few high-tech entrepreneurs would consider $6,000 to be "a lot of......

Full article >>>
'"/>

Source:wistechnology.com By Teresa Esser 08/02/04


Related biology technology :

1. Interview: Dr. William Yasnoff on health records, part 2
2. Interview: Dr. William Yasnoff on patient-centric IT
3. Interview: Dr. Barry Chaiken on healthcare IT
4. Interview: New commerce secretary wants to keep momentum on jobs and business programs
5. Interview: State CIO predicts small businesses and SOA will shape Wisconsin
6. Federal Health Architecture: An Interview with Kathleen Heuer, HHS
7. WTN Interview: HHS Secretary calls for $550 million health care fund to reduce deaths caused by medical errors
8. WTN Exclusive Interview: Cory L. Nettles, Secretary of Commerce
9. WTN Interview: John Pulling, Provia Software
Hitting the Wal-Mart RFID Deadline

10. WTN Interview: Roberta Gassman
11. WTN Interview: Carl Gulbrandsen
WARFs Investment and Portfolio Strategy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... 2016 , ... This CAST literature review and report looks at problems caused ... the economic effects in countries that are major global commodity exporters and importers, which ... risk of low level presence (LLP) puts large volumes of trade worth billions of ...
(Date:12/8/2016)... N.J. , Dec. 8, 2016 Soligenix, ... biopharmaceutical company focused on developing and commercializing products to ... need, announced today that it will be hosting an ... am ET on the origins of innate defense regulators ... a review of oral mucositis and the recently announced ...
(Date:12/8/2016)... 2016 Savannah River Remediation LLC group ... NewTechBio,s NT-MAX Lake & Pond Sludge and ... in conjunction with Hexa Armor/ Rhombo cover manufactured ... Pollutant Discharge Elimination System requirements. The ... history of elevated pH levels, above 8.5, especially ...
(Date:12/8/2016)... 2016  Partnering to fuel Philadelphia,s ... of Southeastern Pennsylvania (" Ben ... of Independence Blue Cross; and Safeguard Scientifics ("Safeguard") (NYSE: ... a $6 million funding initiative over a four year ... Responding to a burgeoning economic vitality in digital health, ...
Breaking Biology Technology:
(Date:12/7/2016)... , Dec. 7, 2016   Avanade is ... Formula One teams in history, exploit biometric data in ... performance and maintain the competitive edge against their rivals ... Avanade has worked with Williams during ... of biometric data (heart rate, breathing rate, temperature and ...
(Date:12/5/2016)... , Dec. 5, 2016  The Office ... today published "Can CT Scans Enhance or Replace ... the potential of supporting or replacing forensic autopsies ... CT scan. In response to recommendations ... is exploring using CT scans as a potential ...
(Date:11/29/2016)... BioDirection, a privately held medical device company developing novel ... concussion and other traumatic brain injury (TBI), announced today ... the U.S. Food and Drug Administration (FDA) to review ... meeting company representatives reviewed plans for clinical development of ... a planned pilot trial. "We are ...
Breaking Biology News(10 mins):